Availability: | |
---|---|
MPR2019-D01/D02/D03/D04
BioTeke
Warm warning: This product is not available for US market.
A.Description
The series of products are designed according to the key mutation sites of each mutant strain. Using multiple ARMS fluorescent PCR method, it can realize multiple rapid identification and detection of coronavirus variants in throat swab samples, and simultaneously amplify the conservative sequence N gene of the coronavirus.
B.Intended Use
In order to better identify the mutant strains of the coronavirus and effectively assist in the prevention and control of the epidemic, Bioteke organized the R&D team to develop the new coronavirus mutant detection kit. On the one hand, it can realize the screening of coronavirus infection, on the other hand, it can be used as a monitoring internal standard for mutation detection, which greatly improves the accuracy of sample test results.
C.Advantages
1. Coronavirus universal (N) gene detection + synchronous detection (S) of key mutation sites can simultaneously achieve coronavirus infection screening and mutant identification.
2. High detection sensitivity, up to 500copies/mL; for composite infected persons,it can detect variant strains as low as 0.1% to 0.01%.
3. Strong specificity, no cross-reactions such as non-specific amplification among different mutations.
4. Compatible with Bioteke rapid nucleic acid extraction technology, nucleic acid-free extraction technology and rapid fluorescence quantitative PCR instrument, and the detection results can be obtained within 45 minutes.
D.Testing data
According to the difference of the Ct value of the mutant and wild-type responses, the samples with mutant virus content as low as 0.1% to 0.01% in the heterogeneous infection can be identified.
Figure 1. Test Results of wild and heterotropic mutant (0.01%) samples at concentration 1 × 107copies/ml
Figure 2. Test Results of wild and heterotropic mutant (0.1%) samples at concentration 1 × 107copies/ml
Figure 3 Test Results of mutant samples at concentration 1 × 103copies/mL
E.Product Qualifications(By Dec.2nd,2022)
Freeze-dried Novel Coronavirus 2019-nCoV+S Mutations Nucleic Acid Detection Kit (Fluorescence PCR) 冻干型新型冠状病毒2019-nCoV+S突变核酸检测试剂盒(荧光 PCR 法)MPR2019-D01, MPR2019-DC01, MPR2019-D02, MPR2019-DC02, MPR2019-D03, MPR2019-DC03, MPR2019-D04, MPR2019-DC04 | |
CE Certification – CIBG Registration Letter | CE 证书-CIBG 注册信 |
CE Certification–EC Declaration of Conformity | CE 证书-EC 符合性声明 |
CE Certificate-CIBG Website notify | CE 证书-CIBG 网站公示 |
Export Qualified Suppliers | 商务部出口白名单 |
Free Sale Certificate-Thailand | 自由销售证明书-泰国 |
Free Sale Certificate-Vietnam | 自由销售证明书-越南 |
Free Sale Certificate-Algeria | 自由销售证明书-阿尔及利亚 |
Free Sale Certificate-Cambodia | 自由销售证明书-柬埔寨 |
Free Sale Certificate-Ghana | 自由销售证明书-加纳 |
ISO 13485 Certificate | ISO 13485 证书 |
ISO 9001 Certificate | ISO 9001 证书 |
ISO 45001 Certificate | ISO 45001职业健康安全管理体系认证证书 |
ISO 14001 Certificate | ISO 14001环境管理体系认证证书 |
IPMS Certificate | 知识产权管理体系认证证书 |
Warm warning: This product is not available for US market.
A.Description
The series of products are designed according to the key mutation sites of each mutant strain. Using multiple ARMS fluorescent PCR method, it can realize multiple rapid identification and detection of coronavirus variants in throat swab samples, and simultaneously amplify the conservative sequence N gene of the coronavirus.
B.Intended Use
In order to better identify the mutant strains of the coronavirus and effectively assist in the prevention and control of the epidemic, Bioteke organized the R&D team to develop the new coronavirus mutant detection kit. On the one hand, it can realize the screening of coronavirus infection, on the other hand, it can be used as a monitoring internal standard for mutation detection, which greatly improves the accuracy of sample test results.
C.Advantages
1. Coronavirus universal (N) gene detection + synchronous detection (S) of key mutation sites can simultaneously achieve coronavirus infection screening and mutant identification.
2. High detection sensitivity, up to 500copies/mL; for composite infected persons,it can detect variant strains as low as 0.1% to 0.01%.
3. Strong specificity, no cross-reactions such as non-specific amplification among different mutations.
4. Compatible with Bioteke rapid nucleic acid extraction technology, nucleic acid-free extraction technology and rapid fluorescence quantitative PCR instrument, and the detection results can be obtained within 45 minutes.
D.Testing data
According to the difference of the Ct value of the mutant and wild-type responses, the samples with mutant virus content as low as 0.1% to 0.01% in the heterogeneous infection can be identified.
Figure 1. Test Results of wild and heterotropic mutant (0.01%) samples at concentration 1 × 107copies/ml
Figure 2. Test Results of wild and heterotropic mutant (0.1%) samples at concentration 1 × 107copies/ml
Figure 3 Test Results of mutant samples at concentration 1 × 103copies/mL
E.Product Qualifications(By Dec.2nd,2022)
Freeze-dried Novel Coronavirus 2019-nCoV+S Mutations Nucleic Acid Detection Kit (Fluorescence PCR) 冻干型新型冠状病毒2019-nCoV+S突变核酸检测试剂盒(荧光 PCR 法)MPR2019-D01, MPR2019-DC01, MPR2019-D02, MPR2019-DC02, MPR2019-D03, MPR2019-DC03, MPR2019-D04, MPR2019-DC04 | |
CE Certification – CIBG Registration Letter | CE 证书-CIBG 注册信 |
CE Certification–EC Declaration of Conformity | CE 证书-EC 符合性声明 |
CE Certificate-CIBG Website notify | CE 证书-CIBG 网站公示 |
Export Qualified Suppliers | 商务部出口白名单 |
Free Sale Certificate-Thailand | 自由销售证明书-泰国 |
Free Sale Certificate-Vietnam | 自由销售证明书-越南 |
Free Sale Certificate-Algeria | 自由销售证明书-阿尔及利亚 |
Free Sale Certificate-Cambodia | 自由销售证明书-柬埔寨 |
Free Sale Certificate-Ghana | 自由销售证明书-加纳 |
ISO 13485 Certificate | ISO 13485 证书 |
ISO 9001 Certificate | ISO 9001 证书 |
ISO 45001 Certificate | ISO 45001职业健康安全管理体系认证证书 |
ISO 14001 Certificate | ISO 14001环境管理体系认证证书 |
IPMS Certificate | 知识产权管理体系认证证书 |
Telephone: 008651068501244
Email : zr@bioteke.cn